NZ covid vaccine developer shuts up shop after funding evaporates

NZ covid vaccine developer shuts up shop after funding evaporates
The vaccine was being developed to cover every variant of the virus and for delivery by any method. (Image: CVC)
Denise McNabb
After spending $5 million from wealthy investors and receiving close to $1m in government grants, Auckland-based Covid 19 Vaccine Corporation (CVC) has shut up shop after failing to secure a further $12m for its first human trial.The vaccine was being developed to cover every variant of the virus and for delivery by any method.The wealthy NZ investors, including richlister Guy Haddleton, pledged the initial finance for the venture developed by life scientist and medical practitioner Robert Feldman and his co-founder, Nelson-based Andy Herbert,...

More Health

Ebos targets pharmacy revenue growth
Markets

Ebos targets pharmacy revenue growth

The dual-listed company cracked revenue of A$13b for the first time in 2024.

Staff reporters 23 Oct 2024
ACC books plunge $7.2b into deficit
Economy

ACC books plunge $7.2b into deficit

The Accident Compensation Corporation concedes there’s room for it to tighten its processes, as it proposes increasing the levies it charges to help pay for rising claims costs.However, the state insurer warns the constrained health system is hampering efforts to get injured peop...

Staff reporters 16 Oct 2024
Why Dunedin Hospital's costs blew out
Finance

Why Dunedin Hospital's costs blew out

Vital's Aaron Hockly says the bigger the project, the harder it is to control.

Dileepa Fonseka 10 Oct 2024
Luxon aims to extend private sector's role in healthcare
Politics

Luxon aims to extend private sector's role in healthcare

The PM wants to make it easier for the public health system to outsource some of its work.

Dileepa Fonseka 08 Oct 2024